'Modeling' relationships among HIV-1 replication, immune activation and CD4+T-cell losses using adjusted correlative analyses

被引:52
作者
Lederman, MM
Kalish, LA
Asmuth, D
Fiebig, E
Mileno, M
Busch, MP
机构
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[2] New England Res Inst, Watertown, MA 02172 USA
[3] Univ Texas, Galveston, TX 77555 USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Brown Univ, Providence, RI 02912 USA
[6] Irwin Mem Blood Ctr, San Francisco, CA USA
[7] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
关键词
HIV; anemia; cytokines; immune activation; CD38; tumor necrosis factor; interleukin-6; b2-microglobulin; cell loss; immune deficiency;
D O I
10.1097/00002030-200005260-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To model the relationships among HIV-1 replication, immune activation and CD4+ T-cell losses in HIV-1 infection. Methods: Cross-sectional analysis of baseline data from the Viral Activation by Transfusion Study. Comparisons of unadjusted and adjusted correlative analyses to establish models for mechanisms of cell loss in AIDS. Results: Using these analyses, significant correlations were found among plasma levels of tumor necrosis factor alpha (TNF alpha) and its type two receptor (TNFrII), interleukin-6 (IL-6), beta(2)-microglobulin, expression of CD38 and HLA-DR on CD8+ T lymphocytes and plasma levels of HIV-1 RNA. When correlations among these indices were adjusted for possible intermediary correlations, the relationship between HIV-1 RNA levels and all plasma markers of immune activation could be accounted for by the correlation between plasma HIV-1 RNA and plasma TNFrII levels. In addition, the negative correlations that both HIV-1 RNA levels and TNFrII levels had with CD4+ T-cell counts were partially accounted for by the correlations of HIV-1 RNA and TNFrII with CD38 expression on CD8+ T cells. In persons with advanced disease (CD4+ T cells < 50 x 10(6)/l) IL-6 levels were inversely correlated with CD4+ T-cell counts. Conclusions: This analysis is consistent with a model wherein HIV-1 replication induces TNF alpha expression that induces multiple other indices of immune activation. In this model, HIV-1 replication and TNF alpha expression induce CD4+ T-cell losses at least in part through mechanisms reflected in heightened CD38 expression. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:951 / 958
页数:8
相关论文
共 20 条
[1]  
Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3
[2]   Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy:: Persistent TNF activation is associated with virologic and immunologic treatment failure [J].
Aukrust, P ;
Müller, F ;
Lien, E ;
Nordoy, I ;
Liabakk, NB ;
Kvale, D ;
Espevik, T ;
Froland, SS .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :74-82
[3]   SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND SOLUBLE TNF RECEPTORS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - CORRELATIONS TO CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL PARAMETERS [J].
AUKRUST, P ;
LIABAKK, NB ;
MULLER, F ;
LIEN, E ;
ESPEVIK, T ;
FROLAND, SS .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :420-424
[4]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[5]   The viral activation transfusion study (VATS): Rationale, objectives, and design overview [J].
Busch, MP ;
Collier, A ;
Gernsheimer, T ;
Carrington, JD ;
Flanigan, TP ;
Kashkari, M ;
Kennedy, M ;
Kumar, PN ;
Lane, TA ;
Mellors, JW ;
Mohandas, K ;
Pollard, RB ;
Viele, M ;
Yomtovian, R ;
Holland, PV ;
McCurdy, PR .
TRANSFUSION, 1996, 36 (10) :854-859
[6]   The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: Correlation between plasma HIV-1 RNA and proinflammatory cytokine levels [J].
Dezube, BJ ;
Lederman, MM ;
Chapman, B ;
Georges, DL ;
Dogon, AL ;
Mudido, P ;
ReisLishing, J ;
Cheng, SL ;
Silberman, SL ;
Crumpacker, CS .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :807-810
[7]   Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements [J].
Fahey, JL ;
Taylor, JMG ;
Manna, B ;
Nishanian, P ;
Aziz, N ;
Giorgi, JV ;
Detels, R .
AIDS, 1998, 12 (13) :1581-1590
[8]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[9]  
Fiebig EW, 1997, CYTOMETRY, V29, P340, DOI 10.1002/(SICI)1097-0320(19971201)29:4<340::AID-CYTO11>3.0.CO
[10]  
2-U